Legal & General Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,644
Closed -$7.07K 3478
2025
Q1
$7.07K Hold
15,644
﹤0.01% 3233
2024
Q4
$7.86K Hold
15,644
﹤0.01% 3291
2024
Q3
$14.2K Hold
15,644
﹤0.01% 3174
2024
Q2
$15.6K Hold
15,644
﹤0.01% 3127
2024
Q1
$23.2K Hold
15,644
﹤0.01% 2910
2023
Q4
$17.1K Hold
15,644
﹤0.01% 3094
2023
Q3
$18.5K Hold
15,644
﹤0.01% 3066
2023
Q2
$22.1K Buy
+15,644
New +$21.6K ﹤0.01% 3080
2022
Q2
Sell
-9,674
Closed -$15K 3597
2022
Q1
$15K Hold
9,674
﹤0.01% 3300
2021
Q4
$24K Hold
9,674
﹤0.01% 3214
2021
Q3
$24K Hold
9,674
﹤0.01% 3217
2021
Q2
$28K Buy
+9,674
New +$25K ﹤0.01% 3162
2020
Q2
Sell
-13,751
Closed -$11K 3436
2020
Q1
$11K Sell
13,751
-7,419
-35% -$7.39K ﹤0.01% 3131
2019
Q4
$19K Hold
21,170
﹤0.01% 3201
2019
Q3
$21K Hold
21,170
﹤0.01% 3112
2019
Q2
$23K Hold
21,170
﹤0.01% 3145
2019
Q1
$28K Buy
21,170
+9,379
+80% +$11.7K ﹤0.01% 2968
2018
Q4
$11K Sell
11,791
-1,686
-13% -$2.58K ﹤0.01% 3255
2018
Q3
$28K Sell
13,477
-3,941
-23% -$8.28K ﹤0.01% 3055
2018
Q2
$31K Buy
17,418
+231
+1% +$465 ﹤0.01% 3002
2018
Q1
$40K Sell
17,187
-8,281
-33% -$19.4K ﹤0.01% 2855
2017
Q4
$48K Hold
25,468
﹤0.01% 2878
2017
Q3
$63K Buy
25,468
+5,762
+29% +$14.3K ﹤0.01% 2839
2017
Q2
$54K Hold
19,706
﹤0.01% 2898
2017
Q1
$59K Sell
19,706
-767
-4% -$2.18K ﹤0.01% 2818
2016
Q4
$65K Buy
20,473
+6,974
+52% +$21.4K ﹤0.01% 2797
2016
Q3
$43K Hold
13,499
﹤0.01% 2598
2016
Q2
$30K Buy
+13,499
New +$33.1K ﹤0.01% 2736

Other funds holding LCTX